US equities
|
MU
$1,045.56
▲+0.00%
AMD
$649.42
▲+0.00%
NVDA
$239.24
▲+0.00%
INTC
$112.50
▲+0.00%
SNDK
$1,660.46
▲+0.00%
SPCX
$171.92
▲+0.00%
PG
$148.41
▲+0.00%
GOOG
$344.59
▲+0.00%
MU
$1,045.56
▲+0.00%
AMD
$649.42
▲+0.00%
NVDA
$239.24
▲+0.00%
INTC
$112.50
▲+0.00%
SNDK
$1,660.46
▲+0.00%
SPCX
$171.92
▲+0.00%
PG
$148.41
▲+0.00%
GOOG
$344.59
▲+0.00%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Latest News about Thomas Hartle
Recent news which mentions Thomas Hartle
Meet Blue Serenity, Canada's First Natural Therapeutic Psilocybin Product For Approved Patients
August 10, 2022
Tickers
OPTHF
Tags
Penny Stocks
Benzinga
News
From
Benzinga
What A Collab! Optimi Health & Patient Advocate Thomas Hartle's New Medical Psilocybin Venture
August 08, 2022
Tickers
OPTHF
Tags
Market News
Health Canada Special Access Program
Cannabis
From
Benzinga